medmix AG's market cap is currently CHF364.76M. The company's EPS TTM is CHF0.39; its P/E ratio is ―; and it has a dividend yield of 5.66%. medmix AG is scheduled to report earnings on July 23, 2025, and the estimated EPS forecast is CHF0.33. See an overview of income statement, balance sheet, and cash flow financials.
